HomeNVCT • NASDAQ
add
Nuvectis Pharma Inc
Previous close
$8.80
Day range
$8.69 - $9.23
Year range
$5.55 - $11.52
Market cap
232.07M USD
Avg Volume
75.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.62M | 18.11% |
Net income | -7.31M | -17.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.63M | 70.69% |
Total assets | 31.71M | 70.41% |
Total liabilities | 13.30M | 49.49% |
Total equity | 18.41M | — |
Shares outstanding | 26.49M | — |
Price to book | 12.22 | — |
Return on assets | -56.59% | — |
Return on capital | -89.77% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.31M | -17.06% |
Cash from operations | -3.97M | -61.22% |
Cash from investing | — | — |
Cash from financing | 166.00K | -95.66% |
Net change in cash | -3.81M | -379.18% |
Free cash flow | -1.53M | -642.92% |
About
Founded
2020
Headquarters
Website
Employees
13
